HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoko Endo Selected Research

arsine

1/2015Possible production of arsenic hemoglobin adducts via exposure to arsine.
4/2014Arsine toxicity is induced by inhalation but not by percutaneous exposure in hairless mice.
1/2011Acute arsine poisoning confirmed by speciation analysis of arsenic compounds in the plasma and urine by HPLC-ICP-MS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoko Endo Research Topics

Disease

17Poisoning
12/2016 - 07/2002
13Neoplasms (Cancer)
11/2019 - 08/2004
6Inflammation (Inflammations)
07/2012 - 02/2006
4Carcinogenesis
04/2015 - 03/2008
3Insulin Resistance
10/2012 - 08/2005
2Proteinuria
11/2019 - 01/2018
2Vomiting
03/2016 - 11/2007
2Hepatocellular Carcinoma (Hepatoma)
03/2012 - 02/2007
2Colitis-Associated Neoplasms
01/2011 - 09/2008
2Ulcerative Colitis
01/2011 - 09/2008
2Colorectal Neoplasms (Colorectal Cancer)
11/2009 - 09/2008
2Infections
04/2007 - 03/2006
1Knee Osteoarthritis
11/2021
1Osteoarthritis
11/2021
1Osteophyte
11/2021
1Leiomyoma (Uterine Fibroids)
05/2021
1Nephritis
11/2019
1Purpura
11/2019
1Rectal Neoplasms (Rectal Cancer)
11/2019
1Vasculitis (Vasculitides)
11/2019
1Thrombotic Microangiopathies
11/2019
1Immunoglobulin Light-chain Amyloidosis
08/2018
1Amyloidosis
08/2018
1Hypoalbuminemia
01/2018
1Hematuria
01/2018
1Hemorrhage
01/2018
1Anemia
01/2018
1Leukopenia
01/2018
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2018
1Respiratory Paralysis
03/2016
1Hemoglobinuria
01/2015
1Hemolysis
04/2014
1Genomic Instability
07/2012
1Polyneuropathies (Polyneuropathy)
01/2012
1Guillain-Barre Syndrome
01/2012
1Xeroderma Pigmentosum (Kaposi's Disease)
10/2010

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
05/2021 - 01/2006
6Cytidine DeaminaseIBA
07/2012 - 02/2007
5CytokinesIBA
03/2012 - 02/2006
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 02/2006
3ArsenicIBA
04/2015 - 01/2011
3arsineIBA
01/2015 - 01/2011
3Peptides (Polypeptides)IBA
03/2012 - 03/2006
3SodiumIBA
08/2005 - 04/2005
2Immunoglobulins (Immunoglobulin)IBA
11/2019 - 08/2018
2Formaldehyde (Formol)FDA Link
08/2018 - 05/2008
2hydroxide ionIBA
04/2015 - 08/2004
2Cacodylic Acid (Cacodylate)IBA
04/2015 - 08/2004
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2012 - 05/2011
2ThiazolidinedionesIBA
10/2012 - 05/2011
2CadmiumIBA
05/2012 - 09/2008
2APOBEC-1 DeaminaseIBA
03/2012 - 03/2006
2NF-kappa B (NF-kB)IBA
03/2008 - 02/2006
2Drinking WaterIBA
11/2007 - 08/2004
2Charcoal (Charbon)IBA
10/2003 - 07/2003
2Cathartics (Purgatives)IBA
10/2003 - 07/2003
1Interleukin-6 (Interleukin 6)IBA
11/2021
1Carrier Proteins (Binding Protein)IBA
11/2021
1Hyaluronan ReceptorsIBA
11/2021
1Hyaluronic Acid (Hyaluronan)IBA
11/2021
1Transcription Factors (Transcription Factor)IBA
05/2021
1Galactose (Galactopyranose)FDA LinkGeneric
11/2019
1Bevacizumab (Avastin)FDA Link
11/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2019
1Immunoglobulin A (IgA)IBA
11/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019
1Dithiothreitol (Cleland's Reagent)IBA
08/2018
1Amyloidogenic ProteinsIBA
08/2018
1TrypsinIBA
08/2018
1ParaffinIBA
08/2018
1DDTIBA
08/2018
1Amyloid (Amyloid Fibrils)IBA
08/2018
1AntibodiesIBA
01/2018
1CreatinineIBA
01/2018
1antiglomerular basement membrane antibodyIBA
01/2018
1SteroidsIBA
01/2018
1PlasticsIBA
04/2017
1Caffeine (No Doz)FDA LinkGeneric
12/2016
1Hazardous Substances (Hazardous Materials)IBA
03/2016
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
03/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2015
1dimethylarsinous acidIBA
04/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1Indicators and Reagents (Reagents)IBA
04/2014
1Glucose (Dextrose)FDA LinkGeneric
10/2012
1A-Form DNA (A-DNA)IBA
07/2012
1Nonprescription Drugs (Patent Medicines)IBA
06/2012
1NucleotidesIBA
03/2012
1eperisoneIBA
09/2011
1afloqualoneIBA
09/2011
1Parasympatholytics (Antispasmodics)IBA
09/2011
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2011
1Arsenicals (Arsenic Compounds)IBA
01/2011
1Syndecan-2IBA
02/2010
1SyndecansIBA
02/2010
1LigandsIBA
02/2010

Therapy/Procedure

4Therapeutics
01/2018 - 05/2006
1Injections
11/2021
1Lasers (Laser)
08/2018
1Plasma Exchange
01/2018